BC
ALKS icon

Bridgefront Capital’s Alkermes ALKS Stock Holding History

Bridgefront Capital’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$258K Sell
7,291
-90
-1% -$2.79K 0.06% 429
2025
Q4 		$207K Buy
+7,381
New +$221K 0.05% 451
2025
Q2 		– Sell
-23,346
Closed -$771K – 589
2025
Q1 		$771K Buy
+23,346
New +$761K 0.22% 137
2021
Q3 		– Sell
-13,597
Closed -$333K – 315
2021
Q2 		$333K Buy
+13,597
New +$302K 0.13% 312
2021
Q1 		– Sell
-22,510
Closed -$449K – 653
2020
Q4 		$449K Buy
+22,510
New +$412K 0.15% 243

Other funds holding ALKS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Bridgefront Capital's ALKS Position: Q1 2026 in Review

Bridgefront Capital reduced its Alkermes (ALKS) stake by 1.2% in Q1 2026, selling an estimated $2.79K and leaving 7,291 shares worth $258K. The position accounts for 0.06% of the portfolio, ranked #429.

Bridgefront Capital first reported a position in ALKS in Q4 2020 and has held it in 5 quarters since. The position peaked at $771K in Q1 2025. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Bridgefront Capital held 7,291 shares of Alkermes worth $258K as of Q1 2026.
  • Bridgefront Capital sold 90 Alkermes shares in Q1 2026, an estimated $2.79K.
  • Alkermes made up 0.06% of Bridgefront Capital's portfolio in Q1 2026, its #429 holding.
  • Bridgefront Capital first reported a position in Alkermes in Q4 2020 and has held it in 5 quarters since.
  • Bridgefront Capital's Alkermes position peaked at $771K in Q1 2025.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.